glp-1 and endometriosis The hidden impact of GLP‐1 receptor agonists on endometrial receptivity implantation GLP-1s and Endometriosis 🔬, Recent

Additionally, a multi-country study found substantial demand for GLP-1 medications among people without medical indications, highlighting the evolving landscape of body image and obesity treatment (Jensen et al., 2025)

Contrave's clinical development program, anchored by the COR trials, presents more moderate efficacy data

Only 10% of those thinking of taking a treatment said the same thing

Simpson, E

Food and Drug Administration's approval of Eli Lilly's once-daily pill orforglipron as a weight loss and obesity treatment this week was the fastest approval of a new medication in decades

Further studies are thus required to better understand the interface of these two clinical challenges